Frequently Asked Questions
The market is segmented based on , By Type (Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis, Others), Diagnosis (Visual Acuity Test, Funduscopic Exam, Ocular Pressure, Slit Lamp Exam, Others), Treatment (Anti-inflammatory, Antibiotics, Immunosuppressive, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
.
The Global Uveitis Market size was valued at USD 588.00 USD Million in 2021.
The Global Uveitis Market is projected to grow at a CAGR of 6% during the forecast period of 2022 to 2029.
The major players operating in the market include Aerie Pharmaceuticals,Allergan,Bausch Health,Merck & Co. ,Pfizer ,Fera Pharmaceuticals,Teva Pharmaceutical Industries ,EyePoint Pharmaceuticals,Amorphex Therapeutics Holdings,Kubota Vision ,Alcon,Astellas Pharma ,Bayer AG,Novartis AG,Carl Zeiss Meditec AG,Nidek Co Ltd,Accutome ,AqueSys,Iridex Corporation.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
